Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude
By Adria Calatayud
Novo Nordisk and Anthropic are teaming up to deploy the Claude artificial-intelligence model with the aim of accelerating the development of new medicines, the latest partnership between the Wegovy maker and an AI lab.
The companies said Wednesday that their collaboration aims to address key challenges in the drug-discovery process by developing targeted solutions and workflows.
Novo has entered into several partnerships with the aim of speeding up the discovery and development of new drugs through AI. Earlier this year, the Danish drugmaker said it would work with ChatGPT maker OpenAI, and also created an AI innovation hub with Amazon Web Services.
As part of the partnership with Anthropic, Novo will test Claude Science to help address scientific problems, it said. The drugmaker also plans to use Anthropic's models to strengthen AI-driven software development, it added.
The companies said the collaboration has been designed with robust data governance and human oversight.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
September 16, 2026 08:38 ET (12:38 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States